Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-19 06:04 am Purchase | 13G | MARINUS PHARMACEUTICALS INC MRNS | TANG CAPITAL PARTNERS LP | 4,502,857 8.2% | 4,502,857 (New Position) | View |
| 2024-03-28 4:00 pm Purchase | 13G | OUTLOOK THERAPEUTICS INC P OTLK | TANG CAPITAL PARTNERS LP | 2,215,851 9.99% | 2,215,851 (New Position) | View |
| 2024-02-16 4:00 pm Sale | 13D | THESEUS PHARMACEUTICALS INC CO THRX | TANG CAPITAL PARTNERS LP | 100 100% | -3,254,926 (-100.00%) | View |
| 2024-02-14 4:00 pm Sale | 13G | ALIGOS THERAPEUTICS INC ALGS | TANG CAPITAL PARTNERS LP | 2,189,847 3% | -626,544 (-22.25%) | View |
| 2024-02-14 4:00 pm Sale | 13G | ANAPTYSBIO INC ANAB | TANG CAPITAL PARTNERS LP | 1,950,609 7.3% | -678,069 (-25.80%) | View |
| 2024-02-14 4:00 pm Sale | 13G | AVROBIO INC AVRO | TANG CAPITAL PARTNERS LP | 0 0% | -2,705,000 (Position Closed) | View |
| 2024-02-14 4:00 pm Sale | 13G | BLUEBIRD BIO INC BLUE | TANG CAPITAL PARTNERS LP | 1,700,000 0.9% | -2,935,528 (-63.33%) | View |
| 2024-02-14 4:00 pm Purchase | 13G | EVOLUS INC EOLS | TANG CAPITAL PARTNERS LP | 3,097,399 5.4% | 58,667 (+1.93%) | View |
| 2024-02-14 4:00 pm Sale | 13G | QUINCE THERAPEUTICS, INC QNCX | TANG CAPITAL PARTNERS LP | 3,220,000 7.5% | -400,000 (-11.05%) | View |
| 2024-02-14 4:00 pm Sale | 13G | TRANSCODE THERAPEUTICS INC RNAZ | TANG CAPITAL PARTNERS LP | 0 0% | -354,700 (Position Closed) | View |
| 2024-02-14 4:00 pm Sale | 13G | ACLARIS THERAPEUTICS INC ACRS | TANG CAPITAL PARTNERS LP | 1,753,335 2.5% | -2,584,820 (-59.58%) | View |
| 2024-02-14 4:00 pm Purchase | 13G | ADICET BIO INC ACET | TANG CAPITAL PARTNERS LP | 5,900,000 7.8% | 3,628,480 (+159.74%) | View |
| 2024-02-14 4:00 pm Purchase | 13G | ALTIMMUNE INC ALT | TANG CAPITAL PARTNERS LP | 2,750,000 5.1% | 49,550 (+1.83%) | View |
| 2024-02-14 4:00 pm Sale | 13G | INFLARX N V COM IFRX | TANG CAPITAL PARTNERS LP | 1,873,753 3.2% | -1,126,247 (-37.54%) | View |
| 2024-02-14 4:00 pm Sale | 13G | KINNATE BIOPHARMA INC KNTE | TANG CAPITAL PARTNERS LP | 2,601,647 5.5% | -364,068 (-12.28%) | View |
| 2024-02-14 4:00 pm Sale | 13G | TCR2 THERAPEUTICS INC TCRR | TANG CAPITAL PARTNERS LP | 0 0% | -4,215,864 (Position Closed) | View |
| 2024-02-14 4:00 pm Unchanged | 13G | TONIX PHARMACEUTICALS HLDG COM TNXP | TANG CAPITAL PARTNERS LP | 0 0% | 0 (Unchanged) | View |
| 2024-02-14 4:00 pm Sale | 13G | BELLEROPHON THERAPEUTICS INC C BLPH | TANG CAPITAL PARTNERS LP | 0 0% | -1,062,619 (Position Closed) | View |
| 2024-02-14 4:00 pm Sale | 13G | BIOATLA INC BCAB | TANG CAPITAL PARTNERS LP | 2,524,076 5.3% | -600,000 (-19.21%) | View |
| 2024-02-14 4:00 pm Sale | 13G | BIONOMICS LTD ADS BNOX | TANG CAPITAL PARTNERS LP | 0 0% | -126,000,000 (Position Closed) | View |